When we get a prescription from the doctor we assume it’s for a drug that’s safe and is the best fit for our needs. At least, that’s how the system is supposed to work.
In the case of pharmaceutical company Alpharma, Inc., a whistleblower filed a complaint that the company provided “kickbacks” to doctors in order to entice them to promote and prescribe its morphine drug Kadian. A lawsuit was then filed alleging Alpharma misrepresented the safety of Kadian and compensated doctors for prescribing the medicine between 2000 and 2008. Kadian is commonly prescribed to patients with chronic pain.
Alpharma has agreed to pay $42.5 million to the U.S. government and certain states to settle the allegations, including awarding $5.33 million to the whistleblower, Debra Parks.
“All consumers have the right to know that their healthcare provider’s judgement about drugs they should take has not been undermined by misinformation or kickbacks from pharmaceutical manufacturers,” said Tony West, assistant attorney general for the Civil Division of the Department of Justice.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.

